Prevest Denpro

480.00
+14.10
(3.03%)
Market Cap
559.20 Cr
EPS
13.45
PE Ratio
31.93
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
686.00
52 Week Low
393.60
PB Ratio
5.49
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,269.20
#1 22,530.80
67.94
#1 1,434.50
24.59
#1 258
34.21
53.84
429.95
2,387.80
87.70
195.30
19.23
18
-44.16
58.67
389.20
2,105.40
69.59
307.90
-0.45
43
-0.97
53.59
614.05
1,023.70
60.14
173.30
40.00
15
-34.92
47.02
480.00
#5 559.20
#5 31.93
#10 59.30
#3 30.58
#4 16
#5 6.25
52.00
282.35
459.70
22.72
132.70
#1 61.83
13
-
59.42
164.50
311.30
19.44
65.60
-16.22
4
-
53.49
278.35
284.80
296.76
122.10
19.24
1
159.52
54.02
166.95
167.20
21.94
101.10
0.60
2
#1 841.20
66.03
83.50
147.60
#1 12.33
122.60
16.98
9
140.00
40.01
Forecast
Actual
Growth Rate
Revenue Growth
30.58 %
Net Income Growth
35.80 %
Cash Flow Change
-81.73 %
ROE
6.49 %
ROCE
4.52 %
EBITDA Margin (Avg.)
-0.69 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
14
14
14
17
14
17
16
20
Expenses
8
9
9
10
9
11
10
12
EBITDA
6
5
5
7
5
7
6
8
Operating Profit %
37 %
33 %
33 %
37 %
34 %
36 %
35 %
35 %
Depreciation
0
0
0
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
Profit Before Tax
5
5
5
6
5
6
6
7
Tax
1
1
1
2
1
2
1
2
Net Profit
4
4
4
5
4
5
5
5
EPS in ₹
3.40
3.04
3.03
3.98
3.06
4.01
3.77
4.28

Balance Sheet

Balance Sheet
2024
Total Assets
95
Fixed Assets
27
Current Assets
68
Capital Work in Progress
0
Investments
2
Other Assets
66
Total Liabilities
95
Current Liabilities
6
Non Current Liabilities
1
Total Equity
89
Reserve & Surplus
77
Share Capital
12

Cash Flow

Cash Flow
2024
Net Cash Flow
10
Investing Activities
-2
Operating Activities
12
Financing Activities
-0

Share Holding

% Holding
Sept 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
73.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.31 %
0.00 %
0.52 %
1.11 %
0.63 %
0.63 %
0.63 %
DIIs
4.15 %
1.21 %
1.16 %
1.16 %
0.95 %
0.95 %
0.61 %
0.71 %
0.00 %
0.68 %
0.68 %
0.68 %
0.71 %
1.28 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.53 %
21.06 %
21.47 %
21.89 %
22.41 %
22.24 %
20.60 %
20.95 %
19.80 %
19.43 %
18.61 %
20.35 %
20.04 %
19.54 %
Others
13.72 %
4.12 %
3.77 %
3.34 %
3.04 %
3.20 %
5.19 %
4.42 %
6.60 %
5.76 %
5.99 %
4.73 %
5.01 %
4.95 %
No of Share Holders
7
1,003
1,256
1,496
1,544
1,613
1,758
1,937
2,040
1,991
1,896
1,822
1,832
1,887

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 470.15 475.30
01 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Feb 2025 579.60 567.85
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 563.05 582.55
06 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2024 621.00 611.65
30 Aug 2024 DIVIDEND Dividend
₹ 1.00 /share
30 Aug 2024 621.00 571.00
23 Aug 2023 DIVIDEND Dividend
₹ 1.00 /share
23 Aug 2023 561.30 455.70

Announcements

Closure of Trading Window4 days ago
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 06, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
Statement Of Deviation And VariationMay 27, 2025
Financial Results For Quarter And Year Ended March 31 2025May 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 2025May 27, 2025
Clarification On Business Operations Amidst Recent Geopolitical DevelopmentsMay 15, 2025
Board Meeting Intimation for Rescheduling Of Board MeetingMay 09, 2025
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended On March 31 2025May 02, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Closure of Trading WindowMar 27, 2025
Integrated Filing (Financial)Feb 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Investment In Axiodent Inc.Feb 01, 2025
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As On Period Ended December 31 2024)Feb 01, 2025
Outcome Of The Board Meeting Held Today I.E. February 01 2025Feb 01, 2025
Board Meeting Outcome for Board Meeting Held On Today I.E. February 01 2025Feb 01, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Saturday February 01 2025.Jan 27, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Closure of Trading WindowDec 28, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 22, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 21, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As On Period Ended September 30, 2024)Nov 12, 2024
Considered And Approved The Unaudited Financial Results (Stanadlone And Consolidated) Of The Company For The Quarter And Half Year Ended On September 30, 2024Nov 11, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E., November 11, 2024Nov 11, 2024
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Monday, November 11, 2024.Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 19, 2024
Closure of Trading WindowSep 30, 2024
Intimation Of Appointment Of Cost Auditor Of The CompanySep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 07, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 06, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Notice Of The 25Th Annual General Meeting Of The Company To Be Held On Friday, September 06, 2024.Aug 13, 2024
Reg. 34 (1) Annual Report.Aug 13, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Quarter Ended On June 30, 2024Aug 08, 2024
Considered And Approved The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On June 30, 2024Aug 08, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E., August 08, 2024Aug 08, 2024
Board Meeting Intimation To Consider And Approve The Unaudited Standalone & Consolidated Financial Results For First Quarter Ended 30.06.2024 And To Recommend Dividend.Jul 31, 2024
Board Meeting Intimation for To Consider Unaudited Standalone & Consolidated Financial Results For First Quarter Ended 30.06.2023 And To Recommend Dividend.Jul 31, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2024
Clarification On Price MovementJul 06, 2024
Clarification sought from Prevest Denpro LtdJul 06, 2024

Technical Indicators

RSI(14)
Neutral
52.00
ATR(14)
Volatile
14.69
STOCH(9,6)
Neutral
41.96
STOCH RSI(14)
Neutral
61.69
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
9.31
UO(9)
Bearish
40.85
ROC(12)
Downtrend But Slowing Down
-0.41
WillR(14)
Neutral
-29.58